We applied exome sequencing and pathway analysis to the study of BPD, a complex disorder.
This is a pilot study on 26 patients with severe BPD selected as extreme phenotypes.
We selected rare or novel variants predicted to have a moderate–high effect.
We identified variants in genes previously associated to BPD.
We identified 5 top candidates by pathway analysis.